Arkema S.A./€AKE
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Arkema S.A.
Arkema S.A. is a global chemicals company headquartered in Colombes, France. It operates in the specialty chemicals and materials industry, focusing on the production of advanced materials, adhesives, and coatings. The company segments its operations into three main areas: High-Performance Materials, Industrial Specialties, and Coating Solutions, catering to sectors such as automotive, construction, and electronics. Founded in 2004 as a spin-off from TotalEnergies, Arkema has developed a significant international presence with operations across Europe, North America, and Asia. Its strategic positioning is underscored by ongoing investments in innovation and sustainable development, aimed at meeting diverse industrial needs. Sources:
Arkema official website
Arkema annual reports and investor relations materials
- Ticker
- €AKE
- Sector
- Materials
- Primary listing
- PAR
- Employees
- 20,648
- Headquarters
- Puteaux, France
- Website
- www.arkema.com
Arkema S.A. Metrics
BasicAdvanced
€4.2B
233.43
€0.24
0.96
€3.60
6.44%
Price and volume
Market cap
€4.2B
Beta
0.96
52-week high
€67.00
52-week low
€45.50
Average daily volume
214K
Dividend rate
€3.60
Financial strength
Current ratio
1.518
Quick ratio
1.069
Long term debt to equity
0.417
Total debt to equity
0.614
Dividend payout ratio (TTM)
527.23%
Interest coverage (TTM)
4.58%
Profitability
EBITDA (TTM)
1,075.5
Gross margin (TTM)
17.83%
Net profit margin (TTM)
0.67%
Operating margin (TTM)
5.07%
Effective tax rate (TTM)
59.29%
Revenue per employee (TTM)
€430,000
Management effectiveness
Return on assets (TTM)
1.72%
Return on equity (TTM)
0.86%
Valuation
Price to earnings (TTM)
233.427
Price to revenue (TTM)
0.475
Price to book
0.71
Price to tangible book (TTM)
4.19
Price to free cash flow (TTM)
11.989
Free cash flow yield (TTM)
8.34%
Free cash flow per share (TTM)
4.665
Dividend yield (TTM)
6.44%
Forward dividend yield
6.44%
Growth
Revenue change (TTM)
-5.74%
Earnings per share change (TTM)
-102.85%
3-year revenue growth (CAGR)
-5.19%
10-year revenue growth (CAGR)
1.66%
3-year earnings per share growth (CAGR)
-67.25%
10-year earnings per share growth (CAGR)
-25.81%
3-year dividend per share growth (CAGR)
1.92%
10-year dividend per share growth (CAGR)
6.60%
What the Analysts think about Arkema S.A.
Analyst ratings (Buy, Hold, Sell) for Arkema S.A. stock.
Analyst projections of the future price of Arkema S.A. stock.
Bulls say / Bears say
Second-quarter EBITDA rose 7.4% year on year and the margin widened to 16.1%, with Adhesives and Coatings leading the improvement. That points to better earnings resilience despite a difficult backdrop. (Arkema)
Arkema expects its major projects to add about €50 million to 2026 EBITDA compared with 2025, and it reaffirmed guidance for slightly higher full-year EBITDA at constant exchange rates. Successful project ramp-ups could support earnings even if demand stays subdued. (Arkema)
Demand remains soft: second-quarter volumes fell 1.8% year on year, while first-half sales declined 3.5% and EBITDA fell 2.7%. Weak conditions in Europe and North America leave the recovery reliant on selected businesses and stronger Asian markets. (Arkema)
The Middle East conflict has raised raw-material, energy and logistics costs and disrupted supply chains. Arkema has used price increases to offset inflation, but further cost rises or weaker demand could make that harder. (Arkema)
Cash generation and balance-sheet headroom are worth watching: second-quarter recurring cash flow was €78 million, while net debt and hybrid bonds stood at €3.6 billion. Higher working-capital needs from rising input prices could constrain cash available for investment or shareholder returns. (Arkema)
Data summarised monthly by Lightyear AI. Last updated on 6 Oct 2026.
Arkema S.A. Financial Performance
Revenues and expenses
Arkema S.A. Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Arkema S.A.
AllEURUSDGBP
Fund name | Fund size | €AKE weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €103M | 1.60% |
Xtrackers MSCI Europe Small Cap£XXSC | $3.6B | 0.23% |
Xtrackers MSCI Europe Small Cap€DX2J | $3.6B | 0.23% |
L&G Global Quality Dividends£LDGG | $353M | 0.06% |
iShares EURO STOXX€SXXEEX | €2.9B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.